Copyright Reports & Markets. All rights reserved.

Global Remdesivir (COVID-19) Market Research Report 2021

Request for Sample of this report
Buy now

1 Remdesivir (COVID-19) Market Overview

  • 1.1 Product Overview and Scope of Remdesivir (COVID-19)
  • 1.2 Remdesivir (COVID-19) Segment by Type
    • 1.2.1 Global Remdesivir (COVID-19) Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 5mg
    • 1.2.3 10mg
    • 1.2.4 50mg
    • 1.2.5 100mg
  • 1.3 Remdesivir (COVID-19) Segment by Application
    • 1.3.1 Remdesivir (COVID-19) Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinics
    • 1.3.4 Drug Store
    • 1.3.5 Others
  • 1.4 Global Remdesivir (COVID-19) Market Size Estimates and Forecasts
    • 1.4.1 Global Remdesivir (COVID-19) Revenue 2016-2027
    • 1.4.2 Global Remdesivir (COVID-19) Sales 2016-2027
    • 1.4.3 Remdesivir (COVID-19) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Remdesivir (COVID-19) Market Competition by Manufacturers

  • 2.1 Global Remdesivir (COVID-19) Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Remdesivir (COVID-19) Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Remdesivir (COVID-19) Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Remdesivir (COVID-19) Manufacturing Sites, Area Served, Product Type
  • 2.5 Remdesivir (COVID-19) Market Competitive Situation and Trends
    • 2.5.1 Remdesivir (COVID-19) Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Remdesivir (COVID-19) Players Market Share by Revenue
    • 2.5.3 Global Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Remdesivir (COVID-19) Retrospective Market Scenario by Region

  • 3.1 Global Remdesivir (COVID-19) Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Remdesivir (COVID-19) Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Remdesivir (COVID-19) Market Facts & Figures by Country
    • 3.3.1 North America Remdesivir (COVID-19) Sales by Country
    • 3.3.2 North America Remdesivir (COVID-19) Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Remdesivir (COVID-19) Market Facts & Figures by Country
    • 3.4.1 Europe Remdesivir (COVID-19) Sales by Country
    • 3.4.2 Europe Remdesivir (COVID-19) Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Remdesivir (COVID-19) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Remdesivir (COVID-19) Sales by Region
    • 3.5.2 Asia Pacific Remdesivir (COVID-19) Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Remdesivir (COVID-19) Market Facts & Figures by Country
    • 3.6.1 Latin America Remdesivir (COVID-19) Sales by Country
    • 3.6.2 Latin America Remdesivir (COVID-19) Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Remdesivir (COVID-19) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Remdesivir (COVID-19) Sales by Country
    • 3.7.2 Middle East and Africa Remdesivir (COVID-19) Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Remdesivir (COVID-19) Historic Market Analysis by Type

  • 4.1 Global Remdesivir (COVID-19) Sales Market Share by Type (2016-2021)
  • 4.2 Global Remdesivir (COVID-19) Revenue Market Share by Type (2016-2021)
  • 4.3 Global Remdesivir (COVID-19) Price by Type (2016-2021)

5 Global Remdesivir (COVID-19) Historic Market Analysis by Application

  • 5.1 Global Remdesivir (COVID-19) Sales Market Share by Application (2016-2021)
  • 5.2 Global Remdesivir (COVID-19) Revenue Market Share by Application (2016-2021)
  • 5.3 Global Remdesivir (COVID-19) Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Gilead Sciences
    • 6.1.1 Gilead Sciences Corporation Information
    • 6.1.2 Gilead Sciences Description and Business Overview
    • 6.1.3 Gilead Sciences Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Gilead Sciences Product Portfolio
    • 6.1.5 Gilead Sciences Recent Developments/Updates
  • 6.2 Bright Gene
    • 6.2.1 Bright Gene Corporation Information
    • 6.2.2 Bright Gene Description and Business Overview
    • 6.2.3 Bright Gene Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Bright Gene Product Portfolio
    • 6.2.5 Bright Gene Recent Developments/Updates
  • 6.3 Hainan Haiyao
    • 6.3.1 Hainan Haiyao Corporation Information
    • 6.3.2 Hainan Haiyao Description and Business Overview
    • 6.3.3 Hainan Haiyao Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Hainan Haiyao Product Portfolio
    • 6.3.5 Hainan Haiyao Recent Developments/Updates
  • 6.4 Kelun Pharma
    • 6.4.1 Kelun Pharma Corporation Information
    • 6.4.2 Kelun Pharma Description and Business Overview
    • 6.4.3 Kelun Pharma Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Kelun Pharma Product Portfolio
    • 6.4.5 Kelun Pharma Recent Developments/Updates
  • 6.5 Hunan Warrant Pharmaceutical
    • 6.5.1 Hunan Warrant Pharmaceutical Corporation Information
    • 6.5.2 Hunan Warrant Pharmaceutical Description and Business Overview
    • 6.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Hunan Warrant Pharmaceutical Product Portfolio
    • 6.5.5 Hunan Warrant Pharmaceutical Recent Developments/Updates
  • 6.6 Borui Bio-Pharmaceutical
    • 6.6.1 Borui Bio-Pharmaceutical Corporation Information
    • 6.6.2 Borui Bio-Pharmaceutical Description and Business Overview
    • 6.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Borui Bio-Pharmaceutical Product Portfolio
    • 6.6.5 Borui Bio-Pharmaceutical Recent Developments/Updates
  • 6.7 Berry Global Group
    • 6.6.1 Berry Global Group Corporation Information
    • 6.6.2 Berry Global Group Description and Business Overview
    • 6.6.3 Berry Global Group Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Berry Global Group Product Portfolio
    • 6.7.5 Berry Global Group Recent Developments/Updates
  • 6.8 Inovio Pharmaceuticals
    • 6.8.1 Inovio Pharmaceuticals Corporation Information
    • 6.8.2 Inovio Pharmaceuticals Description and Business Overview
    • 6.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Inovio Pharmaceuticals Product Portfolio
    • 6.8.5 Inovio Pharmaceuticals Recent Developments/Updates

7 Remdesivir (COVID-19) Manufacturing Cost Analysis

  • 7.1 Remdesivir (COVID-19) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Remdesivir (COVID-19)
  • 7.4 Remdesivir (COVID-19) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Remdesivir (COVID-19) Distributors List
  • 8.3 Remdesivir (COVID-19) Customers

9 Remdesivir (COVID-19) Market Dynamics

  • 9.1 Remdesivir (COVID-19) Industry Trends
  • 9.2 Remdesivir (COVID-19) Growth Drivers
  • 9.3 Remdesivir (COVID-19) Market Challenges
  • 9.4 Remdesivir (COVID-19) Market Restraints

10 Global Market Forecast

  • 10.1 Remdesivir (COVID-19) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Remdesivir (COVID-19) by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Remdesivir (COVID-19) by Type (2022-2027)
  • 10.2 Remdesivir (COVID-19) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Remdesivir (COVID-19) by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Remdesivir (COVID-19) by Application (2022-2027)
  • 10.3 Remdesivir (COVID-19) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Remdesivir (COVID-19) by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Remdesivir (COVID-19) by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    5mg
    10mg
    50mg
    100mg

    Segment by Application
    Hospital
    Clinics
    Drug Store
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Gilead Sciences
    Bright Gene
    Hainan Haiyao
    Kelun Pharma
    Hunan Warrant Pharmaceutical
    Borui Bio-Pharmaceutical
    Berry Global Group
    Inovio Pharmaceuticals

    Buy now